liraglutide had the greatest risk of abdominal pain upper (ROR, 4.63
However, the FDA has received voluntary reports from patients describing emotional numbness, reduced motivation, and depressive symptoms after starting GLP-1 therapy, though causality remains unclear
Without a companion program, its possible to end up with sarcopenic obesity and a higher body fat composition than before starting the meds up to 40% of weight loss can be muscle
In severe cases, consulting a dermatologist could be beneficial
For the vast majority of BPC-157 research applications, the intended method of administration is a subcutaneous (Sub-Q or SQ) injection
5) What are the potential side effects of Full-B12 Injection